On Tuesday, state health officials reported 53% of Minnesotans ages 65 and older have received at least one dose of a COVID-19 vaccine.
The state set a goal to reach 70% of seniors given one vaccination by the end of March so it can move to the next priority category to continue Minnesota’s recovery.
Read More
A coalition of Minnesota doctors wants the governor to prioritize minority groups for the COVID-19 vaccine.
Minnesota Doctors for Health Equity sent a letter Monday to Gov. Tim Walz and Lt. Gov. Peggy Flanagan asking for “ethical, evidence-based, and equitable action” surrounding the state’s COVID-19 vaccine distribution, particularly regarding Phase 1b of the vaccine rollout.
Read More
In a 67-0 vote Monday, the Minnesota Senate passed legislation that will allow dentists to administer the COVID-19 vaccine.
SF 475 is a bill “amending Minnesota Statutes 2020, section 150A.055,” which gives dentists the ability to distribute influenza vaccines. The amendment broadens the original bill, extending to cover COVID-19 vaccinations, too.
Read More
Biotech company Moderna announced Monday that its new COVID-19 vaccine has proven to be 94.5 % effective.
The company said it intends to submit for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration in the coming weeks and expects the EUA to be based on the final analysis of 151 cases and a median follow-up of more than two months.
Read More
The Trump administration is expected to announce that the eventual coronavirus vaccine will be covered by Medicare and Medicaid, Politico reported late Monday.
The administration is expected to change a rule that previously prevented Medicare and Medicaid from covering vaccines that received emergency use authorization from the FDA. The official announcement is expected from the Center for Medicare and Medicaid Services (CMS) Tuesday or Wednesday, according to Politico.
Read More
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.
Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study volunteer develop a serious health issue, requiring a review of safety data.
Read More
CVS Health announced that it would bring on approximately 15,000 additional workers in preparation for the upcoming flu season and an expected rise in coronavirus cases before the distribution of an eventual vaccine.
The hirings will take place before the year’s end, the company said Monday in a statement. Though most of the positions are temporary, many could transition into full-time positions, CVS said.
Read More
The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.
AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer’s illness is a side effect or a coincidence.